Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of the Melanin-Adjusted Blood Oxygen Sensor (MABOS) in ICU Settings

NCT: NCT07799454 · RECRUITING

NCT IDNCT07799454
StatusRECRUITING
Start Date2026-01-06
Completion2026-12-15
SponsorUniversity of North Carolina, Chapel Hill (OTHER)
First posted
Last updated

Brief Summary

Purpose: Investigate the accuracy of the investigators' novel pulse oximeter across a broad range of skin-pigmentations and oxygen saturations. Participants: Up to 120 adult participants admitted to Medical Intensive Care, or Cardiovascular Thoracic Critical Care, Units. Procedures (methods): Participants will have their skin tone measured on each finger using a spectrophotometer. During the study, participants will wear one of the investigators' custom devices - MABOS - on one finger of each hand. Additionally, they will wear a variant of the investigators' device on an additional finger and outer side of the associated wrist. The study team will continuously acquire data from all devices until either 4 Arterial Blood Gas tests have been collected, or 24 hours have elapsed.

Frequently Asked Questions

What is Evaluation of the Melanin-Adjusted Blood Oxygen Sensor (MABOS) in ICU Settings?

Evaluation of the Melanin-Adjusted Blood Oxygen Sensor (MABOS) in ICU Settings is a clinical trial registered under NCT07799454. Current status: RECRUITING.

What is the status of NCT07799454?

The current status of NCT07799454 (Evaluation of the Melanin-Adjusted Blood Oxygen Sensor (MABOS) in ICU Settings) is: RECRUITING.

When did Evaluation of the Melanin-Adjusted Blood Oxygen Sensor (MABOS) in ICU Settings start?

Evaluation of the Melanin-Adjusted Blood Oxygen Sensor (MABOS) in ICU Settings started on 2026-01-06.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.